New guidelines expand BRCA testing and screening for men

FHS
July 27, 2024
4:26 am

More and more studies show that men face risks of cancer from BRCA1 and BRCA2 genetic mutations that are most often associated with breast and ovarian cancers in women.

Aignostics Secures $34M to Advance AI-Powered Pathology and Precision Medicine

What You Should Know: – Aignostics, a leading AI company specializing in pathology data analysis, raised $34M in Series B funding, led by ATHOS with

October 30, 2024

Updated: Recursion to acquire Exscientia to bolster pipeline in one of AI bio’s biggest M&A deals

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 9, 2024

GSK’s Ojjaara receives FDA approval for treating myelofibrosis patients with anaemia

The phase III MOMENTUM trial proved the drug’s efficiency. Credit: LindseyRN via Shutterstock. On 15 September 2023, the US Food and Drug Administration (FDA) approved

September 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.